BioNexus Gene Lab Corp Annual Return On Assets in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
BioNexus Gene Lab Corp quarterly/annual Return On Assets history and growth rate from 2019 to 2023.
  • BioNexus Gene Lab Corp Return On Assets for the quarter ending June 30, 2024 was -19.5 %, a 183% decline year-over-year.
  • BioNexus Gene Lab Corp annual Return On Assets for 2023 was -27 %, a 546% decline from 2022.
  • BioNexus Gene Lab Corp annual Return On Assets for 2022 was -4.18 %, a 154% decline from 2021.
  • BioNexus Gene Lab Corp annual Return On Assets for 2021 was 7.77 %, a 76.4% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -27 -22.8 -546% Jan 1, 2023 Dec 31, 2023
2022 -4.18 -12 -154% Jan 1, 2022 Dec 31, 2022
2021 7.77 -25.1 -76.4% Jan 1, 2021 Dec 31, 2021
2020 32.9 +50.2 Jan 1, 2020 Dec 31, 2020
2019 -17.3 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.